Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA

References

• Wong KCW , HuiEP, LoKWet al. Nasopharyngeal carcinoma: an evolving paradigm. Nat. Rev. Clin. Oncol.18(11), 679–695 (2021).
   PubMed Web of Science ®Google Scholar
• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Chen YP , IsmailaN, ChuaMLKet al. Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II–IVA nasopharyngeal carcinoma: CSCO and ASCO Guideline. J. Clin. Oncol.39(7), 840–859 (2021).
   PubMed Web of Science ®Google Scholar
• Su Z , CaoX, ZouG. Brain and frontal-bone metastasis from nasopharyngeal carcinoma: case report and literature review. Head Neck41(9), e153–e158 (2019).
   PubMed Web of Science ®Google Scholar
• Chen YP , ChanATC, LeQT, BlanchardP, SunY, MaJ. Nasopharyngeal carcinoma. Lancet394(10192), 64–80 (2019).
   PubMed Web of Science ®Google Scholar
• Lee AW , LauKY, HungWMet al. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma. Radiother. Oncol.87(2), 204–210 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y , PanK, LiuLZet al. Sequential cytokine-induced killer cell immunotherapy enhances the efficacy of the gemcitabine plus cisplatin chemotherapy regimen for metastatic nasopharyngeal carcinoma. PLOS ONE10(6), e0130620 (2015).
   PubMed Web of Science ®Google Scholar
• Lv J , ChenY, ZhouGet al. Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nat. Commun.10(1), 3941 (2019).
   PubMedGoogle Scholar
• Rybak LP , MukherjeaD, JajooS, RamkumarV. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J. Exp. Med.219(3), 177–186 (2009).
   PubMed Web of Science ®Google Scholar
• Leeman JE , RomesserPB, ZhouYet al. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol.18(5), e254–e265 (2017).
   PubMed Web of Science ®Google Scholar
• Chan KCA , WooJKS, KingAet al. Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer. N. Engl. J. Med.377(6), 513–522 (2017).
   PubMed Web of Science ®Google Scholar
• Pan JJ , NgWT, ZongJFet al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer122(4), 546–558 (2016).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C , KrailoMD, KrasinMJet al. Treatment of childhood nasopharyngeal carcinoma with induction chemotherapy and concurrent chemoradiotherapy: results of the Children’s Oncology Group ARAR0331 study. J. Clin. Oncol.37(35), 3369–3376 (2019).
   PubMed Web of Science ®Google Scholar
• Kebudi R , BuyukkapuSB, GorgunOet al. Nasopharyngeal carcinoma in children: multimodal treatment and long-term outcome of 92 patients in a single center over a 28-year period. Pediatr. Blood Cancer68(12), e29372 (2021).
   PubMed Web of Science ®Google Scholar
• Kontny U , FranzenS, BehrendsUet al. Diagnosis and treatment of nasopharyngeal carcinoma in children and adolescents – recommendations of the GPOH-NPC study group. Klin. Padiatr.228(3), 105–112 (2016).
   PubMed Web of Science ®Google Scholar
• Lv JW , ZhouGQ, ChenYPet al. Refining the role of lymph node biopsy in survival for patients with nasopharyngeal carcinoma: population-based study from the Surveillance Epidemiology and End-Results registry. Ann. Surg. Oncol.24(9), 2580–2587 (2017).
   PubMed Web of Science ®Google Scholar
• Liu X , TangLL, DuXJet al. Changes in disease failure risk of nasopharyngeal carcinoma over time: analysis of 749 patients with long-term follow-up. J. Cancer8(3), 455–459 (2017).
   PubMed Web of Science ®Google Scholar
• Zhu Y , SongX, LiR, QuanH, YanL. Assessment of nasopharyngeal cancer in young patients aged ≤30 years. Front. Oncol.9, 1179 (2019).
   PubMedGoogle Scholar
• Li Q , YuQ, GongBet al. The effect of magnetic resonance imaging based radiomics models in discriminating stage I–II and III–IVa nasopharyngeal carcinoma. Diagnostics (Basel)13(2), 300 (2023).
   PubMedGoogle Scholar
• Xu BB , LuJ, ZhengZFet al. The predictive value of the preoperative C-reactive protein–albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial data. Gastric Cancer22(5), 1016–1028 (2019).
   PubMed Web of Science ®Google Scholar
• Liao W , TianM, ChenN. Characteristic and novel therapeutic strategies of nasopharyngeal carcinoma with synchronous metastasis. Cancer Manag. Res.11, 8431–8442 (2019).
   PubMed Web of Science ®Google Scholar
• Xu Y , HuangT, MaoM, ZhaiJ, ChenJ. Metastatic patterns and prognosis of de novo metastatic nasopharyngeal carcinoma in the United States. Laryngoscope131(4), E1130–e1138 (2021).
   PubMed Web of Science ®Google Scholar
• Huang XD , ZhouGQ, LvJWet al. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis. Radiother. Oncol.129(2), 389–395 (2018).
   PubMed Web of Science ®Google Scholar
• Jørgensen TL , HallasJ, FriisS, HerrstedtJ. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br. J. Cancer106(7), 1353–1360 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang QX , ZhuangLP, LinZY. Prognostic models for 1-year survival of NPC after radiotherapy in different ages. Eur. Arch. Otorhinolaryngol.278(12), 4955–4965 (2021).
   PubMed Web of Science ®Google Scholar
• Kishawi SK , TsengES, AdomshickVJ, ToweCW, HoVP. Race and trauma mortality: the effect of hospital-level Black–White patient race distribution. J. Trauma Acute Care Surg.92(6), 958–966 (2022).
   PubMed Web of Science ®Google Scholar
• Yang G , LuoB, YangQ, ChenM, YangX, SunJ. Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage. Transl. Cancer Res.9(11), 6939–6954 (2020).
   PubMed Web of Science ®Google Scholar
• Yang X , RenH, YuW, LiH, YangX, FuJ. Bone metastases pattern in newly diagnosed metastatic nasopharyngeal carcinoma: a real-world analysis in the SEER database. Biomed. Res. Int.2020, 2098325 (2020).
   PubMed Web of Science ®Google Scholar
• Qu W , LiS, ZhangM, QiaoQ. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: a large-population retrospective analysis. Cancer Med.9(17), 6147–6158 (2020).
   PubMed Web of Science ®Google Scholar
• Moon PK , MaY, MegwaluUC. Head and neck cancer stage at presentation and survival outcomes among Native Hawaiian and other Pacific Islander patients compared with Asian and White patients. JAMA Otolaryngol. Head Neck Surg.148(7), 636–645 (2022).
   PubMed Web of Science ®Google Scholar
• Hamilton SN , HoC, LaskinJ, ZhaiY, MakP, WuJ. Asian versus non-Asian outcomes in nasopharyngeal carcinoma: a North American population-based analysis. Am. J. Clin. Oncol.39(6), 575–580 (2016).
   PubMed Web of Science ®Google Scholar
• Hughes CK , TsarkJU, KenuiCK, AlexanderGA. Cancer research studies in Native Hawaiians and Pacific Islanders. Ann. Epidemiol.10(Suppl. 8), S49–S60 (2000).
   PubMed Web of Science ®Google Scholar
• Gopalani SV , JanitzAE, MartinezSA, CampbellJE, ChenS. HPV vaccine initiation and completion among Native Hawaiian and Pacific Islander adults, United States, 2014. Asia Pac. J. Public Health33(5), 502–507 (2021).
   PubMed Web of Science ®Google Scholar
• Harari PM , RitterMA, PetereitDG, MehtaMP. Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations. Curr. Probl. Cancer28(1), 7–40 (2004).
   PubMed Web of Science ®Google Scholar
• Denis F , GaraudP, BardetEet al. Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J. Clin. Oncol.22(1), 69–76 (2004).
   PubMed Web of Science ®Google Scholar
• Nguyen NP , MoltzCC, FrankCet al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann. Oncol.15(3), 383–388 (2004).
   PubMed Web of Science ®Google Scholar
• Mittal BB , PauloskiBR, HarafDJet al. Swallowing dysfunction – preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int. J. Radiat. Oncol. Biol. Phys.57(5), 1219–1230 (2003).
   PubMed Web of Science ®Google Scholar
• Maguire PD , MeyersonMB, NealCRet al. Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community. Int. J. Radiat. Oncol. Biol. Phys.58(3), 698–704 (2004).
   PubMed Web of Science ®Google Scholar